Identification of dual mTORC1 and mTORC2 inhibitors in melanoma cells: prodigiosin vs. obatoclax.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Biochemical Pharmacology

• Publication date

  2012-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bcp.2011.11.027PMID 22155350
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The BH3-mimetic GX15-070 induces autophagy, potentiates the cytotoxicity of carboplatin and 5-fluorouracil in esophageal carcinoma cells.

  2010cited by this paper
• mTOR-Dependent Regulation of PHLPP Expression Controls the Rapamycin Sensitivity in Cancer Cells*

  2010cited by this paper
• New insights on the antitumoral properties of prodiginines.

  2010cited by this paper
• Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2

  2009cited by this paper
• Human melanoma cells under endoplasmic reticulum stress are more susceptible to apoptosis induced by the BH3 mimetic obatoclax.

  2009cited by this paper
• Exploring hierarchical refinement techniques for induced fit docking with protein and ligand flexibility

  2009cited by this paper
• The Pharmacology of mTOR Inhibition

  2009cited by this paper
• mTOR Mediated Anti-Cancer Drug Discovery.

  2009cited by this paper
• mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1).

  2008cited by this paper
• Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer.

  2008cited by this paper
• Prodigiosin induces the proapoptotic gene NAG-1 via glycogen synthase kinase-3β activity in human breast cancer cells

  2007cited by this paper
• AKT/PKB signaling: navigating downstream.

  2007cited by this paper
• Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism

  2007cited by this paper
• Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis

  2007cited by this paper
• PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase.

  2007cited by this paper
• TOR signaling in growth and metabolism.

  2006cited by this paper
• Kinetic studies of small molecule interactions with protein kinases using biosensor technology.

  2005cited by this paper
• Structure of S6 Kinase 1 Determines whether Raptor-mTOR or Rictor-mTOR Phosphorylates Its Hydrophobic Motif Site*♦

  2005cited by this paper
• Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton.

  2004cited by this paper
• LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation

  2004cited by this paper
• Structure, regulation and function of PKB/AKT--a major therapeutic target.

  2004cited by this paper
• Targeting mTOR signaling for cancer therapy.

  2003cited by this paper
• Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E.

  2002cited by this paper
• Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action.

  2002cited by this paper
• A phosphoserine/threonine‐binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation

  2002cited by this paper
• mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery.

  2002cited by this paper
• TOR, a central controller of cell growth.

  2000cited by this paper
• Identification of Regulatory Phosphorylation Sites in Mitogen-activated Protein Kinase (MAPK)-activated Protein Kinase-1a/p90 rsk That Are Inducible by MAPK*

  1998cited by this paper
• Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k

  1997cited by this paper
• Mechanism of activation of protein kinase B by insulin and IGF‐1.

  1996cited by this paper
• Large Amplitude Elastic Motions in Proteins from a Single-Parameter, Atomic Analysis.

  1996cited by this paper

• Medical and Nonmedical Applications of Synthetic Transmembrane Anion Transporters

  2025cites this paper
• Promising Prodiginins Biological Activities

  2025cites this paper
• Insight into the anti-cancer and anti-viral therapeutic properties of biological active molecule prodigiosin

  2025cites this paper
• Bir Dizi Prodigiosin ve 1,10-Fenantrolin Türevlerinin Yeni Nesil Etkin Antikanser Tedavi Edici İlaçlar ya da Aktif Farmasötik Maddeler Olarak Tasarımı ve Yapısal İncelenmesi

  2024cites this paper
• Serratia marcescens ATCC 274 increases production of the red pigment prodigiosin in response to Chi phage infection

  2024cites this paper
• Evaluation of the Combinatory Anticancer Effect of Chemotherapeutic Compounds and Prodigiosin against HCT-116, LoVo, and A549 Cell lines

  2024cites this paper
• CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance

  2024cites this paper
• Solid-state fermentation of food waste by Serratia marcescens NCHU05 for prodigiosin production

  2023cites this paper
• Antimetastatic Properties of Prodigiosin and the BH3-Mimetic Obatoclax (GX15-070) in Melanoma

  2022cites this paper
• Rise of the natural red pigment ‘prodigiosin’ as an immunomodulator in cancer

  2022cites this paper
• Design, synthesis, molecular modeling, and bioactivity evaluation of 1,10-phenanthroline and prodigiosin (Ps) derivatives and their Copper(I) complexes against mTOR and HDAC enzymes as highly potent and effective new anticancer therapeutic drugs

  2022cites this paper
• Synthesis, Anticancer Potential and Comprehensive Toxicity Studies of Novel Brominated Derivatives of Bacterial Biopigment Prodigiosin from Serratia marcescens ATCC 27117

  2022cites this paper
• Study on the Anticancer Activity of Prodigiosin from Variants of Serratia Marcescens QBN VTCC 910026

  2022cites this paper
• Characterization of prodigiosin pigment by Serratia marcescens and the evaluation of its bioactivities.

  2022cites this paper
• mTORC1-Mediated Angiogenesis is Required for the Development of Rosacea

  2021cites this paper
• Targeted mass-spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP kinase, and AKT signaling

  2021cites this paper
• Survivin modulation in the antimelanoma activity of prodiginines.

  2020cites this paper
• A comprehensive review on recent trends in production, purification, and applications of prodigiosin

  2020cites this paper
• Prodigiosin Modulates the Immune Response and Could Promote a Stable Atherosclerotic Lession in C57bl/6 Ldlr-/- Mice

  2020cites this paper
• Bacterial Pigment Prodigiosin Demonstrates a Unique Antiherpesvirus Activity That Is Mediated through Inhibition of Prosurvival Signal Transducers

  2020influential citation
• Monte Carlo simulations using PELE to identify a protein–protein inhibitor binding site and pose

  2020cites this paper
• Prodigiosin impairs autophagosome-lysosome fusion that sensitizes colorectal cancer cells to 5-fluorouracil-induced cell death.

  2020cites this paper
• Violacein and Prodiginines from Marine Bacteria

  2020cites this paper
• 2-Keto-D-gluconic acid and prodigiosin producing by a Serratia marcescens

  2020cites this paper
• The production and bioactivity of prodigiosin: quo vadis?

  2020cites this paper
• The pan-Bcl-2 inhibitor obatoclax promotes differentiation and apoptosis of acute myeloid leukemia cells

  2020cites this paper
• Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy

  2019influential citation
• Fast Screening of Inhibitor Binding/Unbinding Using Novel Software Tool CaverDock

  2019cites this paper
• Biocontrol capabilities of the genus Serratia

  2019cites this paper
• Monte Carlo Techniques for Drug Design: The Success Case of PELE

  2018cites this paper
• Comparative Transcriptomics Unravels Prodigiosin's Potential Cancer-Specific Activity Between Human Small Airway Epithelial Cells and Lung Adenocarcinoma Cells

  2018cites this paper
• Prodigiosin stimulates endoplasmic reticulum stress and induces autophagic cell death in glioblastoma cells

  2018cites this paper
• Computational structure‐based drug design: Predicting target flexibility

  2018cites this paper
• Characterisation of non-symbiotic rhizobial and serratia populations from soil

  2018cites this paper
• The role of anti-apoptotic Bcl-2 proteins for colorectal cancer development and progression

  2017cites this paper
• Apoptosis signaling and BCL-2 pathways provide opportunities for novel targeted therapeutic strategies in hematologic malignances.

  2017cites this paper
• Inhibition of Human Enhancer of Zeste Homolog 2 with Tambjamine Analogs

  2017cites this paper
• Multifaceted anticancer activity of BH3 mimetics: Current evidence and future prospects.

  2017cites this paper
• Inhibitory Growth of Oral Squamous Cell Carcinoma Cancer via Bacterial Prodigiosin

  2017cites this paper
• Extracellular extract of Bacillus sp. halotolerant bacterium is cytotoxic to 786.0 human renal adenocarcinoma cell line

  2016cites this paper
• Computational Prediction of HIV-1 Resistance to Protease Inhibitors

  2016cites this paper
• Interaction of prodigiosin with HSA and β-Lg: Spectroscopic and molecular docking studies.

  2016cites this paper
• Overproduction of individual gas vesicle proteins perturbs flotation, antibiotic production and cell division in the enterobacterium Serratia sp. ATCC 39006.

  2016cites this paper
• The BH3 Mimetic Obatoclax Accumulates in Lysosomes and Causes Their Alkalinization

  2016cites this paper
• The natural product prodigiosin binds G-quadruplex DNA

  2016cites this paper
• Experimental Methods to Determine Binding Kinetics

  2015cites this paper
• Modeling protein dynamics and protein-drug interactions with Monte Carlo based techniques

  2015cites this paper
• Bcl-2 family of proteins as drug targets for cancer chemotherapy: the long way of BH3 mimetics from bench to bedside.

  2015cites this paper
• Strategies targeting apoptosis proteins to improve therapy of chronic lymphocytic leukemia.

  2015cites this paper
• The BH3-mimetic obatoclax reduces HIF-1α levels and HIF-1 transcriptional activity and sensitizes hypoxic colon adenocarcinoma cells to 5-fluorouracil.

  2015cites this paper
• Emerging understanding of Bcl-2 biology: Implications for neoplastic progression and treatment.

  2015cites this paper
• Angiogenic growth factors interactome and drug discovery: The contribution of surface plasmon resonance.

  2015cites this paper
• Natural product chemistry and anticancer drug discovery

  2014cites this paper
• Pan-Bcl-2 Inhibitor Obatoclax Delays Cell Cycle Progression and Blocks Migration of Colorectal Cancer Cells

  2014cites this paper
• Targeting antiapoptotic and proapoptotic proteins for novel chronic lymphocytic leukemia therapeutics

  2014cites this paper
• Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy

  2014cites this paper
• Characterization of novel LAP1 complexes and their relevance in DYT1 dystonia

  2014cites this paper
• Identification of a Novel Human LAP1 Isoform That Is Regulated by Protein Phosphorylation

  2014cites this paper
• Influence of B-ring modifications on proton affinity, transmembrane anion transport and anti-cancer properties of synthetic prodigiosenes.

  2014cites this paper
• Phosphoprotein Phosphatase 1 Isoforms Alpha and Gamma Respond Differently to Prodigiosin Treatment and Present Alternative Kinase Targets in Melanoma Cells

  2014influential citation
• Prodigiosin rescues deficient p53 signaling and antitumor effects via upregulating p73 and disrupting its interaction with mutant p53.

  2014cites this paper
• Melanoma never says die

  2014cites this paper
• Pharmaceutical product for the treatment of eye diseases

  2013cites this paper
• PELE web server: atomistic study of biomolecular systems at your fingertips

  2013cites this paper
• Undecylprodigiosin Induced Apoptosis in P388 Cancer Cells Is Associated with Its Binding to Ribosome

  2013cites this paper
• Molecular Interactions of Prodiginines with the BH3 Domain of Anti-Apoptotic Bcl-2 Family Members

  2013cites this paper
• BH3 Mimetics: Status of the Field and New Developments

  2013cites this paper
• Combined targeting of MEK and PI3K/mTOR effector pathways is necessary to effectively inhibit NRAS mutant melanoma in vitro and in vivo

  2013cites this paper
• Prodigiosin activates endoplasmic reticulum stress cell death pathway in human breast carcinoma cell lines.

  2012cites this paper
• Conformational analysis of a model synthetic prodiginine.

  2012cites this paper
• Complexes of prodigiosin (a naturally occurring pyrrolylpyrromethene) with H+, Cl−, HCO3- and CO2: A computational study

  2012cites this paper
• PTEN and melanomagenesis.

  2012cites this paper
• Copy number aberrations of BCL2 and CDKN2A/B identified by array-CGH in thymic epithelial tumors

  2012cites this paper
• Prodigiosin-induced cytotoxicity involves RAD51 down-regulation through the JNK and p38 MAPK pathways in human breast carcinoma cell lines.

  2012cites this paper